Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small integral membrane protein 10-like protein 2B (SMIM10L2B) is a protein-coding gene on the X chromosome, predicted to encode an integral membrane protein with an uncharacterized function[1][2][7][11]. Although it is annotated as a protein-coding gene, its exact biological role, molecular function, and significance as a drug target or biomarker are unknown. SMIM10L2B may have secondary roles as a non-coding RNA based on previous gene symbol assignments, and it has a closely related paralog, SMIM10L2A[1][4]. There is currently no established evidence that SMIM10L2B is a therapeutic target, nor are there reported drugs, mechanisms of action, or clinical biomarkers associated with it[1][2][11]. Key points for data extraction: - This gene/protein is not recognized as a conventional drug target (such as a receptor, enzyme, transporter, or channel), and there is no evidence for therapeutic relevance, drug interactions, or clinical targeting. - The record commonly conflates protein-coding and non-coding RNA nomenclature; the currently correct form appears to be SMIM10L2B as a small integral membrane protein, but previous designations as a lncRNA or "non-protein coding" entity reflect a complicated gene history[1][2][11]. - No direct molecular function, drug interaction, or biomarker use has been established in the scientific literature to date, and its biological function remains largely unknown. If structured extraction is needed for drug discovery or target validation, this entry should be flagged as "not a validated target" due to insufficient evidence of biological function or therapeutic relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small integral membrane protein 10-like protein 2B (SMIM10L2B).